Journal of Natural Products · 2012 · 10 citations · 23 references
MedicineMedicinal ChemistryPharmacologyAntimicrobial PharmacologyDrug DiscoveryMolecular PharmacologyAnthelmintic PharmacologyAntiparasitic PharmacologyBlood ParasitesMalariaProtozoan Host-parasite InteractionsProtozoan PathogenesisAntileishmanial TreatmentAntiprotozoal Drug TherapyHuman African TrypanosomiasisMalaria ParasitesMelting TemperaturePlasmodium FalciparumTreatment Of TrypanosomiasisVisceral Leishmaniasis
Semisynthetic 8,8-dialkyldihydroberberines (8,8-DDBs) were found to possess mid- to low-nanomolar potency against Plasmodium falciparum blood-stage parasites, Leishmania donovani intracellular amastigotes, and Trypanosoma brucei brucei bloodstream forms. For example, 8,8-diethyldihydroberberine chloride (5b) exhibited in vitro IC50 values of 77, 100, and 5.3 nM against these three parasites, respectively. In turn, two 8,8-dialkylcanadines, obtained by reduction of the corresponding 8,8-DDBs, were much less potent against these parasites in vitro. While the natural product berberine is a weak DNA binder, the 8,8-DDBs displayed no affinity for DNA, as assessed by changes in the melting temperature of poly(dA·dT) DNA. Selected 8,8-DDBs showed efficacy in mouse models of visceral leishmaniasis and African trypanosomiasis, with 8,8-dimethyldihydroberberine chloride (5a) reducing liver parasitemia by 46% in L. donovani-infected BALB/c mice when given at an intraperitoneal dose of 10 mg/kg/day for five days. The 8,8-DDBs may thus serve as leads for discovering new antimalarial, antileishmanial, and antitrypanosomal drug candidates.
23
The Role of Plasmodium falciparum Food Vacuole Plasmepsins
Jun Liu, Ilya Y. Gluzman, Mark E. Drew et al. · Journal of Biological Chemistry · 2004 · 208 citations · Full text
Berberine derivatives as antileishmanial drugs
Jonathan L. Vennerstrom, James K. Lovelace, Virginia B. Waits et al. · Antimicrobial Agents and Chemotherapy · 1990 · 126 citations